Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time

[April 09, 2017]

Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time

MENLO PARK, Calif., April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing imetelstat Phase 2/3 trial in myelodysplastic syndromes and the Phase 2 trial in myelofibrosis.

Participants can access the conference call live via telephone by dialing 877-303-9139 (U.S.); 760-536-5195 (international). The conference ID number is 6116409. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast will also be available through the company�s website at�in the Investors section under Events and at The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through May 11, 2017.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations

Primary Logo

[ InfoTech Spotlight's Homepage ]

blog comments powered by Disqus


Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter

infoTECH Whitepapers